Search

Your search keyword '"VALK, VINCENT"' showing total 1,226 results

Search Constraints

Start Over You searched for: Author "VALK, VINCENT" Remove constraint Author: "VALK, VINCENT"
1,226 results on '"VALK, VINCENT"'

Search Results

2. Static payday.

7. Variation in the prices of oncology medicines across Europe and the implications for the future

8. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

10. On the way up? M&A market nears inflec-Mon point.

11. Losing the spark.

12. Billion-Dollar Club: Revenue spikes with price inflation.

13. Sideways: Compensation stagnated in 2022.

14. Paints & coatings: demand grows as costs

15. Industrial gases: emerging markets, new applications lift growth: leading industrial gases companies including Air Liquide, Air Products, Linde, and Praxair are showing resilience in a tough economic climate. Plant start-ups, particularly in emerging markets, are driving industry growth, and gas applications in the energy and environmental sectors have created a range of additional opportunities

17. Distribution: moving past the downturn

18. Executive compensation: big paydays return

19. Refinery catalysts: suppliers tap emerging markets: refinery catalysts makers expect moderate growth in the next five years, driven almost entirely by demand growth in the developing countries and their adoption of stricter fuel standards. Meanwhile, turmoil in the rare earths sector has forced suppliers to scramble for alternatives to a crucial raw material

20. Executive compensation: still feeling the pinch

22. Executive compensation: downturn dings pay packages

23. Distribution: riding out the storm

24. Pricing of oral generic cancer medicines in 25 European countries; findings and implications

26. Fully funded? Industry eyes capex in a high-rate world.

27. Pricing of oral generic cancer medicines in 25 European countries; findings and implications

29. M&A: return of the megadeal: after surviving the Great Recession and its aftermath, industry executives have turned to growth strategies over the past year, including large-scale M&A. Billion-dollar plus deals have made a big comeback since early 2011

30. Institutional investors: gauging interest in chemical stocks

31. Slowdown: financial turmoil fuels industry uncertainty

32. Electronic chemicals: plugging into surging markets

33. Rare earths: shortages, price spike spark supply scramble

34. Growing pains: Lithium ramp-up faces challenges.

35. M&A cash in the balance

36. M&A hitting the target: Chemical merger and acquisition (M&A) activity is springing back, but experts say large, transformative deals are likely to be few for the foreseeable future. Still, the value of the sector's M&A deals in the first half of 2010 is already well above the total completed in 2009

37. Biochemical characterization and bioinformatic analysis of two large multi-domain enzymes from Microbacterium aurum B8.A involved in native starch degradation

38. Distribution: charting path to recovery

39. M&A activity level chills

44. ICL acquires US-based ag formulator for $60M.

45. Cinven's Envu to acquire FMC specialty solutions business.

46. Billion-Dollar Club: Global growth returned in 2021.

47. Boom year: Pay rises, again, for industry's top execs in 2021.

50. Sun Chemical, Mitra Chem sign iron phosphate deal.

Catalog

Books, media, physical & digital resources